Therapeutic drug monitoring of liposomal amphotericin B in children. Are we there yet? A systematic review.
Tony LaiChin-Yen YeoBradley RockliffMichael StokesHannah Yejin KimBen J MaraisAndrew J McLachlanJan Willem C AlffenaarPublished in: The Journal of antimicrobial chemotherapy (2024)
While significant PK variability was observed in children, evidence to support routine L-amb TDM was limited. Further studies on efficacy and toxicity benefits are required before routine TDM of L-amb can be recommended.